期刊文献+

Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis 被引量:5

Effects of Dan-shao-hua-xian on expression of PPAR-gamma and NF-kappa B in rat liver fibrosis
下载PDF
导出
摘要 BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and nuclear factor kappa B (NF-kappa B) play important roles in liver fibrosis. This study aimed to investigate the effects of Dan-shao-hua-xian, a preparation of traditional Chinese medicine, on the expression of PPAR-gamma and NF-kappa B in the fibrotic livers of rats. METHODS: Seventy Wistar rats were randomly divided into 4 groups: treatment (model, 8 weeks+treatment, 8 weeks; group A), natural recovery (model, 8 weeks+ saline, 8 weeks; group B), model (model only, 8 weeks; group Q, and control (normal, untreated, 16 weeks; group D). Each group consisted of 20 rats (except for group D, which had 10). Fibrotic liver models were induced in rats by subcutaneous injection of CCI4, oral administration of alcohol and a high-lipid/low-protein diet for 8 weeks. After the models were established, the rats in group A were orally given Dan-shao-hua-xian capsules daily for another 8 weeks. Then, the liver indices serum hyaluronic acid (HA), tumor necrosis factor-alpha (TNF-alpha) and alanine aminotransferase (ALT) were measured. The degree of hepatic fibrosis was evaluated by optical microscopy. Hydroxyproline (Hyp) in the liver tissue was determined. The expression of PPAR-gamma was detected by immunohistochemical techniques. The protein levels of PPAR-gamma and NF-kappa B were determined by Western blotting. RESULTS: The concentrations of serum HA, TNF-alpha and Hyp in group C increased compared with group D (P<0.05), and they decreased in group A compared with group C (P<0.05). The expression of PPAR-gamma in group C decreased compared with group D (P<0.05), and it increased in group A compared with groups B and C (P<0.05). Similarly, Western blotting showed that the expression of PPAR-gamma in group C decreased compared with group D, and it increased in group A compared with group C. The expression of NF-kappa B increased in group C compared with group D (P<0.05), and it decreased in group A compared with group C (P<0.05). CONCLUSION: Dan-shao-hua-xian capsules enhance the expression of PPAR-gamma but decrease that of TNF-alpha and NF-kappa B in the liver tissues of CCI4-induced hepatic fibrotic rats. These effects may play a role in its activity in treating hepatic fibrosis. BACKGROUND: Peroxisome proliferator-activated receptor gamma (PPAR-gamma) and nuclear factor kappa B (NF-kappa B) play important roles in liver fibrosis. This study aimed to investigate the effects of Dan-shao-hua-xian, a preparation of traditional Chinese medicine, on the expression of PPAR-gamma and NF-kappa B in the fibrotic livers of rats. METHODS: Seventy Wistar rats were randomly divided into 4 groups: treatment (model, 8 weeks+treatment, 8 weeks; group A), natural recovery (model, 8 weeks+ saline, 8 weeks; group B), model (model only, 8 weeks; group Q, and control (normal, untreated, 16 weeks; group D). Each group consisted of 20 rats (except for group D, which had 10). Fibrotic liver models were induced in rats by subcutaneous injection of CCI4, oral administration of alcohol and a high-lipid/low-protein diet for 8 weeks. After the models were established, the rats in group A were orally given Dan-shao-hua-xian capsules daily for another 8 weeks. Then, the liver indices serum hyaluronic acid (HA), tumor necrosis factor-alpha (TNF-alpha) and alanine aminotransferase (ALT) were measured. The degree of hepatic fibrosis was evaluated by optical microscopy. Hydroxyproline (Hyp) in the liver tissue was determined. The expression of PPAR-gamma was detected by immunohistochemical techniques. The protein levels of PPAR-gamma and NF-kappa B were determined by Western blotting. RESULTS: The concentrations of serum HA, TNF-alpha and Hyp in group C increased compared with group D (P<0.05), and they decreased in group A compared with group C (P<0.05). The expression of PPAR-gamma in group C decreased compared with group D (P<0.05), and it increased in group A compared with groups B and C (P<0.05). Similarly, Western blotting showed that the expression of PPAR-gamma in group C decreased compared with group D, and it increased in group A compared with group C. The expression of NF-kappa B increased in group C compared with group D (P<0.05), and it decreased in group A compared with group C (P<0.05). CONCLUSION: Dan-shao-hua-xian capsules enhance the expression of PPAR-gamma but decrease that of TNF-alpha and NF-kappa B in the liver tissues of CCI4-induced hepatic fibrotic rats. These effects may play a role in its activity in treating hepatic fibrosis.
机构地区 Affiliated Hosp
出处 《Hepatobiliary & Pancreatic Diseases International》 SCIE CAS 2008年第2期179-184,共6页 国际肝胆胰疾病杂志(英文版)
关键词 Dan-shao-hua-xian capsules peroxisome proliferator-activated receptors NF-kappa B hepatic fibrosis Dan-shao-hua-xian capsules peroxisome proliferator-activated receptors NF-kappa B hepatic fibrosis
  • 相关文献

参考文献4

二级参考文献47

  • 1李玮,曹路敏,陈早姣,李万,杜庆玲,陈桂萍.Study on the Effects of FCu-IUD and FICu-IUD on Matrix metalloproteinases in Human Uterine Flushing and Endometrium[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2002,22(1):9-11. 被引量:1
  • 2Zhang, J,Cao, YJ,Liu, WM,Zhao, BS,Zeng, GQ,Duan, EK.Expression of matrix metallo-proteinase-28 in human normal cytotrophoblast cells and a choriocarcinoma cell line,JEG-3[J].Chinese Science Bulletin,2002,47(9):732-736. 被引量:4
  • 3Frasier K, William S, Kothapalli D, et al. Stimulation of fibroblast cell growth, Matrix production, and granulation tissue formation by connective growth factor [J] . J Invest Dermatol, 1996,107:404 - 411.
  • 4Chen MM, Lam A, Abraham, et al. CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis [J] . J Mol Cell Cardiol, 2000, 32(10) :1805 - 1819.
  • 5Kasaragod AB, Lucia MS, Cabirac G, et al. Connective Tissue Growth Factor Expression in Pediatric Myofibroblastic Tumors[J] . Pediatr Dev Pathol, 2001, 3(4) :37 - 45.
  • 6Ito Y, Goldschmeding R, Bende R, et al. Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis[J] . J Am Soc Nephrol, 2001, 12(3):472 -484.
  • 7Valerie P, Delphine D, Michel V, et al. Expression of connective tissue growth factor in experiment rat and human liver fibrosis[J]. Hepatology, 1999, 30:968 - 976.
  • 8Williams EJ, Gaca MD, Brigstock DR, et al. Increased expression of connective tissue growth factor in fibrotic human liver and in activated hepatic stellate cells[J]. J Hepatol, 2000, 32(5):754- 761.
  • 9Abou- Shady M, Friess H, Zimmermann A, et al. Connective tissue growth factor in human liver cirrhosis [J] . Liver, 2000, 20(4) :296 - 304.
  • 10Li CX, Cheng ML, Huang LH. et al. The protective effects of traditional chinese medicine prescription ,Han - Dan - Gan - Le,on CCIA - induced liver fibrosis in rats [J] . Am J Chin Med,1998, 26:325 - 332.

共引文献22

同被引文献50

引证文献5

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部